Enveda Biosciences: Funding, Investors & Team (Aug 2026)
Enveda Biosciences is a biotechnology company that creates new medications from plants, utilizing the intricacies of nature to address major healthcare issues. Through advancements in knowledge graphs, machine learning, and metabolomics, they identify innovative small molecules for the future. Their technologies streamline the process of discovering small molecules and new targets for complex diseases. By exploring new chemical spaces and mechanisms of action, they are revolutionizing the treatment of difficult diseases like fibrosis and neurodegeneration. Established in 2019, Enveda is based in Boulder, Colorado.
Enveda Biosciences has raised $224M across 4 funding rounds on record, the most recent a Series B of $55.0M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Enveda Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Enveda Biosciences Funding Rounds
Enveda Biosciences raised $51.0M in an undisclosed round announced in Jun 2021.
1.5 years later, a Series B of $55.0M was announced in Dec 2022.
3 months later, an undisclosed round of $62.5M was announced in Mar 2023.
1.3 years later, a Series B of $55.0M was announced in Jun 2024.
Enveda Biosciences Founders and Leadership Team
Contact details for the Enveda Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Enveda Biosciences Funding Compared to Other Biotechnology Startups
Enveda Biosciences' latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enveda Biosciences in Biotechnology and Boulder
Companies Similar to Enveda Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Enveda Biosciences Funding FAQs
What does Enveda Biosciences do?
Enveda Biosciences is a biotechnology company that creates new medications from plants, utilizing the intricacies of nature to address major healthcare issues. Through advancements in knowledge graphs, machine learning, and metabolomics, they identify innovative small molecules for the future. Their technologies streamline the process of discovering small molecules and new targets for complex diseases. By exploring new chemical spaces and mechanisms of action, they are revolutionizing the treatment of difficult diseases like fibrosis and neurodegeneration. Established in 2019, Enveda is based in Boulder, Colorado.
How much funding has Enveda Biosciences raised?
Enveda Biosciences has raised $224M across 4 rounds on record. The most recent is a Series B of $55.0M announced in Jun 2024.
When did Enveda Biosciences last raise funding?
Enveda Biosciences' most recent funding round on record is a Series B of $55.0M, announced in Jun 2024.
Who is the CEO of Enveda Biosciences?
Viswa Colluru is listed as CEO at Enveda Biosciences.
Where is Enveda Biosciences headquartered?
Enveda Biosciences is based in Boulder, Colorado, United States.
How many employees does Enveda Biosciences have?
Enveda Biosciences is in the 101-250 employee band.
How does Enveda Biosciences' funding compare to other Biotechnology startups?
Enveda Biosciences' latest round of $55.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Enveda Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enveda Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.